Categories AlphaGraphs, Earnings, Health Care
Key metrics from Biogen’s (BIIB) Q4 2024 earnings results
Biogen Inc. (NASDAQ: BIIB) reported its fourth quarter 2024 earnings results today.
Total revenue increased 3% year-over-year to $2.5 billion.
Net income attributable to Biogen Inc. was $266.8 million, or $1.83 per share, compared to $249.7 million, or $1.71 per share, last year. Adjusted EPS grew 17% YoY to $3.44.
For full-year 2025, the company expects total revenue to decline by a mid-single digit percentage at constant currency versus full-year 2024. Adjusted EPS is expected to be $15.25-16.25.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Accenture (ACN) likely to extend revenue growth in Q4 2025 despite challenges
Accenture (NYSE: ACN) has consistently delivered quarterly revenue growth across its operating segments this year, pushing both top-line and earnings above analysts' estimates. That momentum is expected to continue when
Darden Restaurants (DRI): A look at the restaurant chain’s performance in Q1 2026
Shares of Darden Restaurants, Inc. (NYSE: DRI) were down over 2% on Friday. The stock has dropped 17% year-to-date. The restaurant operator delivered sales and earnings growth for the first
Intuit (INTU) reaffirms first-quarter and fiscal 2026 financial guidance
Financial technology company Intuit Inc. (NASDAQ: INTU) has published its financial outlook, reaffirming first-quarter and full-year guidance. For the first quarter of fiscal 2026, the company continues to expect revenue
